---
title: "SELECT trial shows cardiovascular risk reduction in non-diabetics taking semaglutide"
date: "2023-11-14T14:21:37.000Z"
publishedDate: "14 novembre 2023"
summary: "Results of the SELECT clinical trial, presented at the American Heart Association’s 2023 Scientific Sessions (11–13 November, Philadelphia, USA), have shown that overweight or obese people without diabetes taking the drug semaglutide for more than three years had a 20% lower risk of heart attack, stroke or death due to cardiovascular disease and lost an [&#8230;] The post SELECT trial shows cardiovascular risk reduction in non-diabetics taking semaglutide appeared first on Cardiovascular News ."
importance: ""
sourceUrl: "https://cardiovascularnews.com/select-trial-shows-cardiovascular-risk-reduction-in-non-diabetics-taking-semaglutide/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2023-11-14-select-trial-shows-cardiovascular-risk-reduction-in-non-diabetics-taking-semaglutide"
imageUrl: "https://cardiovascularnews.com/wp-content/uploads/sites/14/2023/11/towfiqu-barbhuiya-J6g_szOtMF4-unsplash.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/select-trial-shows-cardiovascular-risk-reduction-in-non-diabetics-taking-semaglutide/"
---

![SELECT trial shows cardiovascular risk reduction in non-diabetics taking semaglutide](https://cardiovascularnews.com/wp-content/uploads/sites/14/2023/11/towfiqu-barbhuiya-J6g_szOtMF4-unsplash.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/select-trial-shows-cardiovascular-risk-reduction-in-non-diabetics-taking-semaglutide/*

## L’essentiel

Results of the SELECT clinical trial, presented at the American Heart Association’s 2023 Scientific Sessions (11–13 November, Philadelphia, USA), have shown that overweight or obese people without diabetes taking the drug semaglutide for more than three years had a 20% lower risk of heart attack, stroke or death due to cardiovascular disease and lost an [&#8230;] The post SELECT trial shows cardiovascular risk reduction in non-diabetics taking semaglutide appeared first on Cardiovascular News .

## Lien source

https://cardiovascularnews.com/select-trial-shows-cardiovascular-risk-reduction-in-non-diabetics-taking-semaglutide/
